A Study to Test if TEV-48574 is Effective in Relieving Asthma
- Study Title
- A 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Proof-of-Concept Study to Evaluate the Efficacy and Safety of TEV-48574 in Adults With T2-low/Non-T2 Severe Uncontrolled Asthma
- Teva Identifier
- TV48574-AS-20031 | 2020-001927-15
- ClinicalTrials.gov Identifier
- NCT04545385
- Study Status
- Terminated
- Trial Condition(s)
- Asthma
- Interventions
- Drug: TEV-48574 | Drug: Placebo
- EudraCT Number
- 2020-001927-15
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- October 07, 2020 - January 17, 2022
- Phase
- Phase 2